2
项与 培非格司亭生物类似药(Lupin Ltd.) 相关的临床试验An Open-label, Randomized, Comparative, Parallel Group Study to Assess the Immunogenicity of Lupin's Peg-filgrastim Versus Neulasta® as an Adjunct to Chemotherapy in Patients With Breast Cancer
The purpose of this study is to compare the immunogenicity of Peg-filgrastim versus Neulasta® as an adjunct to chemotherapy in patients with breast cancer
An open-label, multi-center, randomized, active controlled, comparative, phase III clinical study to assess efficacy and safety of Lupin?s Filgrastim versus Neupogen® as an adjunct to chemotherapy for prevention of neutropenia in patients with non-myeloid malignancies
100 项与 培非格司亭生物类似药(Lupin Ltd.) 相关的临床结果
100 项与 培非格司亭生物类似药(Lupin Ltd.) 相关的转化医学
100 项与 培非格司亭生物类似药(Lupin Ltd.) 相关的专利(医药)
100 项与 培非格司亭生物类似药(Lupin Ltd.) 相关的药物交易